AfterPlan
NDC 62756-723, levonorgestrel, tablet, from SUN PHARMACEUTICAL INDUSTRIES, INC..
- Product NDC
- 62756-723
- Status
- Listed
- Labeler
- SUN PHARMACEUTICAL INDUSTRIES, INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA202635
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62756-723 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVONORGESTREL1.5 mg/1
Pharmacologic classes
Inhibit Ovum Fertilization [PE]; Progesterone Congeners [CS]; Progesterone Congeners [CS]; Progestin [EPC]; Progestin-containing Intrauterine Device [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62756-723-60 | 62756072360 | 1 BLISTER PACK in 1 CARTON (62756-723-60) / 1 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 62756-723 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62756-723 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62756-723. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.